Literature DB >> 12646257

Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains.

Johannes V Swinnen1, Paul P Van Veldhoven, Leen Timmermans, Ellen De Schrijver, Koen Brusselmans, Frank Vanderhoydonc, Tine Van de Sande, Hannelore Heemers, Walter Heyns, Guido Verhoeven.   

Abstract

Fatty acid synthase (FAS) is a key metabolic enzyme catalyzing the synthesis of long-chain saturated fatty acids. It plays a central role in the production of surfactant in fetal lungs, in the supply of fatty components of milk, and in the conversion and storage of energy in liver and adipose tissue. Remarkably high levels of FAS expression are found in the majority of human epithelial cancers. As the role of FAS in cancer cells remains largely unknown, we have initiated studies to assess the fate of newly synthesized lipids in cancer cells and have estimated the contribution of FAS to the synthesis of specific lipid classes by treating the cells with small interfering RNAs targeting FAS. Here, we show that in cancer cells FAS plays a major role in the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. These are raft-aggregates implicated in key cellular processes including signal transduction, intracellular trafficking, cell polarization, and cell migration. These findings reveal a novel role for FAS, provide important new insights into the otherwise poorly understood mechanisms underlying the control of lipid composition of membrane microdomains, and point to a link between FAS overexpression and dysregulation of membrane composition and functioning in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646257     DOI: 10.1016/s0006-291x(03)00265-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  85 in total

Review 1.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

2.  A mutant of HBx (HBxDelta127) promotes hepatoma cell growth via sterol regulatory element binding protein 1c involving 5-lipoxygenase.

Authors:  Qi Wang; Wei-ying Zhang; Li-hong Ye; Xiao-dong Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-02-22       Impact factor: 6.150

3.  C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.

Authors:  Evan Y Yu; Mark Muzi; Joy A Hackenbracht; Brian B Rezvani; Jeanne M Link; Robert Bruce Montgomery; Celestia S Higano; Janet F Eary; David A Mankoff
Journal:  Clin Nucl Med       Date:  2011-03       Impact factor: 7.794

4.  Renal oncocytoma on 1-11C acetate positron emission tomography: Case report and literature review.

Authors:  Jabi Shriki; Venkatesh Murthy; Jeffrey Brown
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

Review 5.  Polyunsaturated fatty acid metabolism in prostate cancer.

Authors:  Isabelle M Berquin; Iris J Edwards; Steven J Kridel; Yong Q Chen
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

6.  Lipoprotein lipase links dietary fat to solid tumor cell proliferation.

Authors:  Nancy B Kuemmerle; Evelien Rysman; Portia S Lombardo; Alison J Flanagan; Brea C Lipe; Wendy A Wells; Jason R Pettus; Heather M Froehlich; Vincent A Memoli; Peter M Morganelli; Johannes V Swinnen; Luika A Timmerman; Leila Chaychi; Catherine J Fricano; Burton L Eisenberg; William B Coleman; William B Kinlaw
Journal:  Mol Cancer Ther       Date:  2011-01-31       Impact factor: 6.261

7.  Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease.

Authors:  Noemí Fabelo; Virginia Martín; Gabriel Santpere; Raquel Marín; Laia Torrent; Isidre Ferrer; Mario Díaz
Journal:  Mol Med       Date:  2011-06-22       Impact factor: 6.354

8.  Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.

Authors:  Yekaterina Y Zaytseva; Piotr G Rychahou; Pat Gulhati; Victoria A Elliott; William C Mustain; Kathleen O'Connor; Andrew J Morris; Manjula Sunkara; Heidi L Weiss; Eun Y Lee; B Mark Evers
Journal:  Cancer Res       Date:  2012-01-19       Impact factor: 12.701

9.  Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.

Authors:  Sadia Raab; Alexis Gadault; Ninon Very; Amélie Decourcelle; Steffi Baldini; Céline Schulz; Marlène Mortuaire; Quentin Lemaire; Stéphan Hardivillé; Vanessa Dehennaut; Ikram El Yazidi-Belkoura; Anne-Sophie Vercoutter-Edouart; Ganna Panasyuk; Tony Lefebvre
Journal:  Cell Mol Life Sci       Date:  2021-05-27       Impact factor: 9.261

10.  ras-Induced up-regulation of CTP:phosphocholine cytidylyltransferase α contributes to malignant transformation of intestinal epithelial cells.

Authors:  Daniel J Arsenault; Byong H Yoo; Kirill V Rosen; Neale D Ridgway
Journal:  J Biol Chem       Date:  2012-11-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.